|
1
|
Tao Q and Chan AT: Nasopharyngeal
carcinoma: molecular pathogenesis and therapeutic developments. Exp
Rev Mol Med. 9:1–24. 2007.PubMed/NCBI
|
|
2
|
Chou J, Lin YC, Kim J, You L, Xu Z, He B
and Jablons DM: Nasopharyngeal carcinoma - review of the molecular
mechanisms of tumorigenesis. Head Neck. 30:946–963. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takada K and Nanbo A: The role of EBERs in
oncogenesis. Semin Cancer Biol. 11:461–467. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Komano J, Maruo S, Kurozumi K, Oda T and
Takada K: Oncogenic role of Epstein-Barr virus-encoded RNAs in
Burkitt’s lymphoma cell line Akata. J Virol. 73:9827–9831.
1999.
|
|
5
|
Yamamoto N, Takizawa T, Iwanaga Y, Shimizu
N and Yamamoto N: Malignant transformation of B lymphoma cell line
BJAB by Epstein-Barr virus-encoded small RNAs. FEBS Lett.
484:153–158. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kitagawa N, Goto M, Kurozumi K, Maruo S,
Fukayama M, Naoe T, Yasukawa M, Hino K, Suzuki T, Todo S and Takada
K: Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt’s
lymphoma growth through interleukin-10 induction. EMBO J.
19:6742–6750. 2000.PubMed/NCBI
|
|
7
|
Yang L, Aozasa K, Oshimi K and Takada K:
Epstein-Barr virus (EBV)-encoded RNA promotes growth of
EBV-infected T cells through interleukin-9 induction. Cancer Res.
64:5332–5337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wong HL, Wang X, Chang RC, et al: Stable
expression of EBERs in immortalized nasopharyngeal epithelial cells
confers resistance to apoptotic stress. Mol Carcinog. 44:92–101.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iwakiri D, Eizuru Y, Tokunaga M and Takada
K: Autocrine growth of Epstein-Barr virus-positive gastric
carcinoma cells mediated by an Epstein-Barr virus-encoded small
RNA. Cancer Res. 63:7062–7067. 2003.PubMed/NCBI
|
|
10
|
Iwakiri D, Sheen TS, Chen JY, Huang DP and
Takada K: Epstein-Barr virus-encoded small RNA induces insulin-like
growth factor 1 and supports growth of nasopharyngeal
carcinoma-derived cell lines. Oncogene. 24:1767–1773. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang DP, Ho JH, Poon YF, Chew EC, Saw D,
Lui M, Li CL, Mak LS, Lai SH and Lau WH: Establishment of a cell
line (NPC/HK1) from a differentiated squamous carcinoma of the
nasopharynx. Int J Cancer. 26:127–132. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW,
Tsang YS, Wong N, Whitney BM and Lee JC: Nasopharyngeal carcinoma
cell line (C666-1) consistently harbouring Epstein-Barr virus. Int
J Cancer. 83:121–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chan SY, Choy KW, Tsao SW, Tao Q, Tang T,
Chung GT and Lo KW: Authentication of nasopharyngeal carcinoma
tumor lines. Int J Cancer. 122:2169–2171. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gebäck T, Schulz MM, Koumoutsakos P and
Detmar M: TScratch: a novel and simple software tool for automated
analysis of monolayer wound healing assays. Biotechniques.
46:265–274. 2008.PubMed/NCBI
|
|
15
|
Edgar R, Domrachev M and Lash AE: Gene
Expression Omnibus: NCBI gene expression and hybridization array
data repository. Nucleic Acids Res. 30:207–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Busson P, Ganem G, Flores P, Mugneret F,
Clausse B, Caillou B, Braham K, Wakasugi H, Lipinski M and Tursz T:
Establishment and characterization of three transplantable
EBV-containing nasopharyngeal carcinomas. Int J Cancer. 42:599–606.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cory G: Scratch-wound assay. Cell
Migration: Developmental Methods and Protocols, Methods in
Molecular Biology. Wells CM and Parsons M: 769. Springer
Science+Business Media, LLC; New York, NY: pp. 25–30. 2011,
View Article : Google Scholar
|
|
18
|
Sturn A, Quackenbush J and Trajanoski Z:
Genesis: cluster analysis of microarray data. Bioinformatics.
18:207–208. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brusselmans K, Vrolix R, Verhoeven G and
Swinnen JV: Induction of cancer cell apoptosis by flavonoids is
associated with their ability to inhibit fatty acid synthase
activity. J Biol Chem. 280:5636–5645. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Daker M, Ahmad M and Khoo ASB:
Quercetin-induced inhibition and synergistic activity with
cisplatin - a chemotherapeutic strategy for nasopharyngeal
carcinoma cells. Cancer Cell Int. 12:342012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hirsch HA, Iliopoulos D, Joshi A, Zhang Y,
Jaeger SA, Bulyk M, Tsichlis PN, Shirley Liu X and Struhl K: A
transcriptional signature and common gene networks link cancer with
lipid metabolism and diverse human diseases. Cancer Cell.
17:348–361. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chung NS and Wasan KM: Potential role of
the low-density lipoprotein receptor family as mediators of
cellular drug uptake. Adv Drug Deliv Rev. 56:1315–1334. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tatidis L, Gruber A and Vitols S:
Decreased feedback regulation of low density lipoprotein receptor
activity by sterols in leukemic cells from patients with acute
myelogenous leukemia. J Lipid Res. 38:2436–2445. 1997.
|
|
24
|
Chen Y and Hughes-Fulford M: Human
prostate cancer cells lack feedback regulation of low-density
lipoprotein receptor and its regulator, SREBP2. Int J Cancer.
91:41–45. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sekine Y, Koike H, Nakano T, Nakajima K,
Takahashi S and Suzuki K: Remnant lipoproteins induced
proliferation of human prostate cancer cell, PC-3 but not LNCaP,
via low density liporprotein receptor. Cancer Epidemiol. 33:16–23.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lum DF, McQuaid KR, Gilbertson VL and
Hughes-Fulford M: Coordinate up-regulation of low-density
lipoprotein receptor and cyclo-oxygenase-2 gene expression in human
colorectal cells and in colorectal adenocarcinoma biopsies. Int J
Cancer. 83:162–166. 1999. View Article : Google Scholar
|
|
27
|
Rao KN: The significance of the
cholesterol biosynthetic pathway in cell growth and carcinogenesis
(review). Anticancer Res. 15:309–314. 1995.PubMed/NCBI
|
|
28
|
Gueddari N, Favre G, Hachem H, Marek E, Le
Gaillard F and Soula G: Evidence for up-regulated low density
lipoprotein receptor in human lung adenocarcinoma cell line A549.
Biochimie. 75:811–819. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shiroeda O, Yamaguchi N and Kawai K:
Stimulation of low density lipoprotein receptor activity by
conditioned medium from a human cancer cell line. Cancer Res.
47:4630–4633. 1987.PubMed/NCBI
|
|
30
|
Shimano H: Sterol regulatory
element-binding proteins (SREBPs): transcriptional regulators of
lipid synthetic genes. Prog Lipid Res. 40:439–452. 2001. View Article : Google Scholar
|
|
31
|
Weber LW, Boll M and Stampfl A:
Maintaining cholesterol homeostasis: sterol regulatory
element-binding proteins. World J Gastroenterol. 10:3081–3087.
2004.PubMed/NCBI
|
|
32
|
Streicher R, Kotzka J, Müller-Wieland D,
Siemeister G, Munck M, Avci H and Krone W: SREBP-1 mediates
activation of the low density lipoprotein receptor promoter by
insulin and insulin-like growth factor-1. J Biol Chem.
271:7128–7133. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Foretz M, Guichard C, Ferré P and Foufelle
F: Sterol regulatory element binding protein-1c is a major mediator
of insulin action on the hepatic expression of glucokinase and
lipogenesis-related genes. Proc Natl Acad Sci USA. 12737–12742.
1999. View Article : Google Scholar
|
|
34
|
LaVoie HA, Garmey JC, Day RN and Veldhuis
JD: Concerted regulation of low density lipoprotein receptor gene
expression by follicle-stimulating hormone and insulin-like growth
factor 1 in porcine granulosa cells: promoter activation, messenger
ribonucleic acid stability and sterol feedback. Endocrinology.
140:178–186. 1999.
|
|
35
|
Kuhajda FP: Fatty-acid synthase and human
cancer: new perspectives on its role in tumor biology. Nutrition.
16:202–208. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Menendez JA and Lupu R: Fatty acid
synthase and the lipogenic phenotype in cancer pathogenesis. Nat
Rev Cancer. 7:763–777. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kuhajda FP: Fatty acid synthase and
cancer: new application of an old pathway. Cancer Res.
66:5977–5980. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang F, Cui Y and Cao P: Effect of
quercetin on proliferation and apoptosis of human nasopharyngeal
carcinoma HEN1 cells. J Huazhong Univ Sci Technolog Med Sci.
28:369–372. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yoshida M, Sakai T, Hosokawa N, Marui N,
Matsumoto K, Fujioka A, Nishino H and Aoike A: The effect of
quercetin on cell cycle progression and growth of human gastric
cancer cells. FEBS Lett. 260:10–13. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yoshida M, Yamamoto M and Nikaido T:
Quercetin arrests human leukemic T-cells in late G1 phase of the
cell cycle. Cancer Res. 52:6676–6681. 1992.PubMed/NCBI
|
|
41
|
Lupu R and Menendez JA: Pharmacological
inhibitors of Fatty Acid Synthase (FASN)-catalyzed endogenous fatty
acid biogenesis: a new family of anti-cancer agents? Curr Pharm
Biotechnol. 7:483–493. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pizer ES, Chrest FJ, DiGiuseppe JA and Han
WF: Pharmacological inhibitors of mammalian fatty acid synthase
suppress DNA replication and induce apoptosis in tumor cell lines.
Cancer Res. 58:4611–4615. 1998.PubMed/NCBI
|
